384 related articles for article (PubMed ID: 8403689)
1. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
Kamei T; Nakagawa H; Uchiyama F; Fukuyama J
Rinsho Shinkeigaku; 1993 Jun; 33(6):660-2. PubMed ID: 8403689
[TBL] [Abstract][Full Text] [Related]
2. [Value of intravenous immunoglobulins. A case of Guillain-Barré syndrome].
Hidou M; Olivier J; Vivant JF
Rev Neurol (Paris); 1992; 148(11):706-8. PubMed ID: 1303562
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.
Lancet; 1997 Jan; 349(9047):225-30. PubMed ID: 9014908
[TBL] [Abstract][Full Text] [Related]
4. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
Imai N; Miyata K; Terayama Y; Ishihara N
Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulins i.v.: a new approach to the treatment of Guillain-Barré syndrome.
Fasanaro AM; Pizza V; Rossi V
Minerva Med; 1996; 87(1-2):17-20. PubMed ID: 8610020
[TBL] [Abstract][Full Text] [Related]
6. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency.
Oczko-Walker M; Manousakis G; Wang S; Malter JS; Waclawik AJ
J Clin Neuromuscul Dis; 2010 Dec; 12(2):55-61. PubMed ID: 21386771
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immune globulin in the Guillain-Barré syndrome.
van der Meché FG
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):43-7. PubMed ID: 8033434
[TBL] [Abstract][Full Text] [Related]
8. Plasma exchange and i.v.-immunoglobulins: new approaches to the treatment of Guillain-Barre' syndrome.
Fasanaro AM; Pizza V; Stella L
Acta Neurol (Napoli); 1992; 14(4-6):369-80. PubMed ID: 1293980
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
van der Meché FG; Schmitz PI
N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
[TBL] [Abstract][Full Text] [Related]
10. [Functional recovery in Guillain-Barre syndrome: benefits of plasma exchange].
Cassuto-Viguier E; Sanderson F; Kullman B; Quaranta JF; Montagne N; Gueyraud A; Therre C; Duplay H
Ann Med Interne (Paris); 1988; 139 Suppl 1():43-5. PubMed ID: 3247991
[TBL] [Abstract][Full Text] [Related]
11. [Guillain-Barré syndrome treated with high doses of immunoglobulins by the intravenous route: 4 cases].
Uldry PA; Bogousslavsky J; Regli F
Rev Neurol (Paris); 1991; 147(8-9):573-6. PubMed ID: 1962066
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
Tsai CP; Wang KC; Liu CY; Sheng WY; Lee TC
J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of chronic inflammatory demyelinating polyradiculoneuropathy with plasma exchange or intravenous immunoglobulin.
Choudhary PP; Hughes RA
QJM; 1995 Jul; 88(7):493-502. PubMed ID: 7633875
[TBL] [Abstract][Full Text] [Related]
14. [Present treatment of Guillain-Barre syndrome].
Raphaël JC
Bull Acad Natl Med; 2004; 188(1):87-94; discussion 94-5. PubMed ID: 15368928
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Guillain-Barré syndrome in the US hospitals.
Alshekhlee A; Hussain Z; Sultan B; Katirji B
J Clin Neuromuscul Dis; 2008 Sep; 10(1):4-10. PubMed ID: 18772694
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome.
Kuitwaard K; de Gelder J; Tio-Gillen AP; Hop WC; van Gelder T; van Toorenenbergen AW; van Doorn PA; Jacobs BC
Ann Neurol; 2009 Nov; 66(5):597-603. PubMed ID: 19938102
[TBL] [Abstract][Full Text] [Related]
19. [Guillain-Barré syndrome: epidemiological, clinical and therapeutic insight].
Raphaël JC; Sharshar T
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S35-40. PubMed ID: 10896987
[TBL] [Abstract][Full Text] [Related]
20. Small volume plasma exchange in Guillain-Barre syndrome: experience in 25 patients.
Tharakan J; Jayaprakash PA; Iyer VP
J Assoc Physicians India; 1990 Aug; 38(8):550-3. PubMed ID: 2246192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
